Jones Financial Companies Lllp Has $6.51 Million Stock Position in CVS Health Co. (NYSE:CVS)

Jones Financial Companies Lllp grew its holdings in CVS Health Co. (NYSE:CVS) by 18.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 145,011 shares of the pharmacy operator’s stock after acquiring an additional 22,994 shares during the quarter. Jones Financial Companies Lllp’s holdings in CVS Health were worth $6,510,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CVS. SRS Capital Advisors Inc. increased its position in shares of CVS Health by 28.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 2,552 shares of the pharmacy operator’s stock valued at $115,000 after acquiring an additional 569 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in shares of CVS Health by 7.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 10,725 shares of the pharmacy operator’s stock worth $471,000 after purchasing an additional 760 shares in the last quarter. Cape Investment Advisory Inc. boosted its holdings in shares of CVS Health by 54.9% in the 4th quarter. Cape Investment Advisory Inc. now owns 1,275 shares of the pharmacy operator’s stock valued at $57,000 after buying an additional 452 shares during the last quarter. Keynote Financial Services LLC grew its stake in shares of CVS Health by 14.2% in the fourth quarter. Keynote Financial Services LLC now owns 32,385 shares of the pharmacy operator’s stock valued at $1,454,000 after buying an additional 4,034 shares in the last quarter. Finally, Proffitt & Goodson Inc. increased its stake in shares of CVS Health by 10.6% during the 4th quarter. Proffitt & Goodson Inc. now owns 11,321 shares of the pharmacy operator’s stock worth $508,000 after purchasing an additional 1,084 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a report on Tuesday, December 3rd. TD Cowen boosted their price target on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. Truist Financial raised their target price on shares of CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, UBS Group dropped their price objective on CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a report on Tuesday, February 11th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $69.83.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Michael F. Mahoney acquired 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.24% of the company’s stock.

CVS Health Stock Down 1.4 %

CVS stock opened at $64.82 on Tuesday. The firm has a 50-day moving average price of $54.74 and a 200-day moving average price of $56.53. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $81.72 billion, a P/E ratio of 17.71, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, equities research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.10%. CVS Health’s payout ratio is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.